1. Aoki, Y., Suzuki, H. and Itoh, H. (1986): Changes in polyamine metabolism in rat liver after oral administration of alpha-naphthylisothiocyanate. J. Toxicol. Sci., 11, 95-104.
2. Brown, R.S.Jr. (2000): Predicting outcome of transplantation for cholestatic liver disease: Child-Pugh or Mayo risk score? Liver Transpl., 6, 759-761.
3. Chisholm, J.W. and Dolphin, P.J. (1996): Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis. J. Lipid. Res., 37, 1086-1098.
4. Glaser, S.S., Onori, P., Wise, C., Yang, F., Marzioni, M., Alvaro, D., Franchitto, A., Mancinelli, R., Alpini, G., Munshi, M.K. and Gaudio, E. (2010): Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.Dig. Liver Dis., 42, 245-252.
5. Goldfarb, S., Singer, E.J. and Popper, H. (1962): Experimental cholangitis due to alpha-naphthyl-isothiocyanate (ANIT). Am. J. Pathol., 40, 685-698.